# A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults

> **NCT06967181** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **CyanVac LLC** · enrollment: 60 (actual)

## Conditions studied

- Mumps

## Interventions

- **BIOLOGICAL:** CVM150
- **BIOLOGICAL:** CVM26
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06967181
- **Lead sponsor:** CyanVac LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-14
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06967181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06967181, "A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06967181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*